Determinants of long-acting reversible contraceptive (LARC) use by adolescent girls and young women

P Bharadwaj, H Akintomide, N Brima… - … European Journal of …, 2012 - Taylor & Francis
Objectives To identify factors relevant for adolescents and young women in their selection of
a contraceptive method and reasons for acceptance or rejection of long-acting reversible …

Copper IUD continuation, unwanted effects and cost consequences at 1 year in users aged under 30–a secondary analysis of the EURAS-IUD study

H Akintomide, N Brima, DJ Mansour… - The European Journal of …, 2021 - Taylor & Francis
Objective To conduct a secondary analysis of continuation, unwanted effects and cost
consequences at 1 year in copper intrauterine device (IUD) users aged under 30 in the European …

Randomized trial of the effect of tailored versus standard use of the combined oral contraceptive pill on continuation rates at 1 year

…, A Copas, U Sauer, C Wilkinson, H Akintomide… - Contraception, 2013 - Elsevier
Background There is growing interest from women and clinicians in extended or tailored use
of the combined oral contraceptive (COC) pill. Potential advantages include less bleeding, …

Higher discontinuation rate with a standard-sized compared to a small-sized 'gold standard'copper intrauterine device: a case-control review

H Akintomide, P Barnes, N Brima… - BMJ Sexual & …, 2019 - srh.bmj.com
Background T-shaped intrauterine devices (IUDs) with a copper surface area of 380 mm 2
and copper bands on the transverse arms are the most effective types of copper-containing …

Patients' experiences and providers' observations on pain during intrauterine device insertion

H Akintomide, N Brima, RDE Sewell… - The European Journal …, 2015 - Taylor & Francis
Objective To determine women's (patients’) experiences of intrauterine device (IUD) insertion
under our current practice and the extent to which these agreed with the observations of …

A comparison of the expected and actual pain experienced by women during insertion of an intrauterine contraceptive device

N Brima, H Akintomide, V Iguyovwe… - Open Access Journal of …, 2015 - Taylor & Francis
Objective To compare the expected and actual pain experienced with the insertion of
intrauterine contraception in women, and to determine whether either of these are related to their …

Systematic review of copper intrauterine contraception continuation in young nulliparous women based on intrauterine device type

H Akintomide, A James, M Moffat, P Barnes… - BMJ open, 2022 - bmjopen.bmj.com
Objectives No copper intrauterine device (IUD) type is known to better suit young nulliparous
women who tend to experience higher rates of IUD discontinuation compared with their …

Nomegestrol acetate/17-beta estradiol: a review of efficacy, safety, and patient acceptability

H Akintomide, S Panicker - Open Access Journal of Contraception, 2015 - Taylor & Francis
Nomegestrol acetate (NOMAC) 2.5 mg with 17-beta estradiol (E2) 1.5 mg is a new combined
oral contraceptive (COC) formulation and is the first monophasic E2 pill to be marketed, …

The use of local anaesthesia for intrauterine device insertion by health professionals in the UK

H Akintomide, RDE Sewell… - Journal of Family Planning …, 2013 - srh.bmj.com
Background Pain associated with the insertion of an intrauterine device (IUD) is a known
barrier to intrauterine contraception use in the UK. It is good practice for health professionals to …

Presenting risk information in sexual and reproductive health care

AL David, H Akintomide - Journal of Family Planning and Reproductive …, 2016 - srh.bmj.com
Objectives Presenting risk information to patients is an important part of clinical encounters.
Good risk communication improves patient satisfaction with their care and the decisions they …